Dual-radionuclide brain SPECT for the differential diagnosis of parkinsonism.

4Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Parkinsonism is a neurological syndrome characterized by tremor, bradykinesia, rigidity, and postural instability. The underlying causes of parkinsonism are numerous. It is of paramount importance to make clean distinction among these diseases. However, the differential diagnosis of parkinsonism is challenging. Simultaneous dual-radionuclide brain SPECT allows us to assess both blood perfusion and dopamine transporter function under the identical physiological conditions. This approach has been proven to improve the differential diagnosis of parkinsonism. The simultaneous (99m)Tc-ECD/(123)I-FP-CIT brain SPECT protocols, which are used for the differential diagnosis of idiopathic Parkinson's disease and multiple system atrophy as well as corticobasal degeneration and progressive supranuclear palsy, are presented.

Cite

CITATION STYLE

APA

El Fakhri, G., & Ouyang, J. (2011). Dual-radionuclide brain SPECT for the differential diagnosis of parkinsonism. Methods in Molecular Biology (Clifton, N.J.), 680, 237–246. https://doi.org/10.1007/978-1-60761-901-7_16

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free